HUIMIN WANG - 08 Feb 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Japan & Intercontinental
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 08 Feb 2022
Net transactions value: -$561,594
Form type: 4
Filing time: 08 Feb 2022, 19:12:13 UTC
Previous filing: 07 Jan 2022
Next filing: 08 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Options Exercise	$138,176	+6,350	+6.5%	$21.76	104,377	08 Feb 2022	Direct	F1
transaction	EW	Common Stock	Sale	$699,770	-6,350	-6.1%	$110.20	98,027	08 Feb 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Employee Stock Option (Right to Acquire)	Options Exercise	$0	-6,350	-100%	$0.000000^*	0	08 Feb 2022	Common Stock	6,350	$21.76	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.